Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029126623> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W2029126623 endingPage "278" @default.
- W2029126623 startingPage "275" @default.
- W2029126623 abstract "In Brief Purpose: To report the short-term anatomic and visual acuity response after intravitreal injection of bevacizumab (Avastin, Genentech) in patients with proliferative diabetic retinopathy complicated by vitreous hemorrhage. Methods: Two patients with vitreous hemorrhage due to proliferative diabetic retinopathy were treated with at least one intravitreal injection of bevacizumab 1.25 mg in 0.05 mL. The patients underwent Snellen visual acuity testing, ophthalmoscopic examination, and fluorescein angiography at baseline and follow-up visits. Results: Both patients had proliferative diabetic retinopathy with vitreous hemorrhage extensive enough to preclude panretinal photocoagulation. Following intravitreal injection of bevacizumab both patients experienced improvement in visual acuity starting within the first week. At 1 month of follow-up one patient had 2 lines of improvement in visual acuity and the other 5 lines. Each patient had regression of retinal neovascularization at 1 month of follow-up. Repeat injection was given to one patient at the 1-month follow-up because of slight leakage from neovascularization on the nerve, and to the other patient at 3 months because the retinal neovascularization showed early signs of reperfusion. The vitreous hemorrhage in each patient showed partial resolution at 1 week and nearly complete regression at 1 month. No adverse events were observed in either patient. Conclusions: Initial treatment results of patients with vitreous hemorrhage and proliferative diabetic retinopathy did not reveal any short-term safety concerns. Intravitreal bevacizumab resulted in marked regression of neovascularization and rapid resolution of vitreous hemorrhage. The favorable short-term results suggest further study is needed in a larger group of patients. Two patients with proliferative diabetic retinopathy and vitreous hemorrhage that prevented laser panretinal photocoagulation were given intravitreal bevacizumab. After injection there was not only the rapid regression of the neovascularization, but apparent clearing of vitreous hemorrhage." @default.
- W2029126623 created "2016-06-24" @default.
- W2029126623 creator A5059501787 @default.
- W2029126623 creator A5071947447 @default.
- W2029126623 date "2006-03-01" @default.
- W2029126623 modified "2023-10-12" @default.
- W2029126623 title "INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY COMPLICATED BY VITREOUS HEMORRHAGE" @default.
- W2029126623 cites W1539571840 @default.
- W2029126623 cites W1974568895 @default.
- W2029126623 cites W1976409243 @default.
- W2029126623 cites W2004643661 @default.
- W2029126623 cites W2026490523 @default.
- W2029126623 cites W2028212562 @default.
- W2029126623 cites W2064892180 @default.
- W2029126623 cites W2128535483 @default.
- W2029126623 cites W2137893922 @default.
- W2029126623 cites W2234822182 @default.
- W2029126623 cites W2324588265 @default.
- W2029126623 cites W4212945288 @default.
- W2029126623 cites W4297917733 @default.
- W2029126623 doi "https://doi.org/10.1097/00006982-200603000-00004" @default.
- W2029126623 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16508426" @default.
- W2029126623 hasPublicationYear "2006" @default.
- W2029126623 type Work @default.
- W2029126623 sameAs 2029126623 @default.
- W2029126623 citedByCount "468" @default.
- W2029126623 countsByYear W20291266232012 @default.
- W2029126623 countsByYear W20291266232013 @default.
- W2029126623 countsByYear W20291266232014 @default.
- W2029126623 countsByYear W20291266232015 @default.
- W2029126623 countsByYear W20291266232016 @default.
- W2029126623 countsByYear W20291266232017 @default.
- W2029126623 countsByYear W20291266232018 @default.
- W2029126623 countsByYear W20291266232019 @default.
- W2029126623 countsByYear W20291266232020 @default.
- W2029126623 countsByYear W20291266232021 @default.
- W2029126623 countsByYear W20291266232022 @default.
- W2029126623 countsByYear W20291266232023 @default.
- W2029126623 crossrefType "journal-article" @default.
- W2029126623 hasAuthorship W2029126623A5059501787 @default.
- W2029126623 hasAuthorship W2029126623A5071947447 @default.
- W2029126623 hasConcept C118487528 @default.
- W2029126623 hasConcept C126322002 @default.
- W2029126623 hasConcept C134018914 @default.
- W2029126623 hasConcept C141071460 @default.
- W2029126623 hasConcept C2776694085 @default.
- W2029126623 hasConcept C2777104736 @default.
- W2029126623 hasConcept C2777802072 @default.
- W2029126623 hasConcept C2778257484 @default.
- W2029126623 hasConcept C2778271429 @default.
- W2029126623 hasConcept C2778313320 @default.
- W2029126623 hasConcept C2779829184 @default.
- W2029126623 hasConcept C2780248432 @default.
- W2029126623 hasConcept C2780394083 @default.
- W2029126623 hasConcept C2780827179 @default.
- W2029126623 hasConcept C2781242345 @default.
- W2029126623 hasConcept C555293320 @default.
- W2029126623 hasConcept C71924100 @default.
- W2029126623 hasConceptScore W2029126623C118487528 @default.
- W2029126623 hasConceptScore W2029126623C126322002 @default.
- W2029126623 hasConceptScore W2029126623C134018914 @default.
- W2029126623 hasConceptScore W2029126623C141071460 @default.
- W2029126623 hasConceptScore W2029126623C2776694085 @default.
- W2029126623 hasConceptScore W2029126623C2777104736 @default.
- W2029126623 hasConceptScore W2029126623C2777802072 @default.
- W2029126623 hasConceptScore W2029126623C2778257484 @default.
- W2029126623 hasConceptScore W2029126623C2778271429 @default.
- W2029126623 hasConceptScore W2029126623C2778313320 @default.
- W2029126623 hasConceptScore W2029126623C2779829184 @default.
- W2029126623 hasConceptScore W2029126623C2780248432 @default.
- W2029126623 hasConceptScore W2029126623C2780394083 @default.
- W2029126623 hasConceptScore W2029126623C2780827179 @default.
- W2029126623 hasConceptScore W2029126623C2781242345 @default.
- W2029126623 hasConceptScore W2029126623C555293320 @default.
- W2029126623 hasConceptScore W2029126623C71924100 @default.
- W2029126623 hasIssue "3" @default.
- W2029126623 hasLocation W20291266231 @default.
- W2029126623 hasLocation W20291266232 @default.
- W2029126623 hasOpenAccess W2029126623 @default.
- W2029126623 hasPrimaryLocation W20291266231 @default.
- W2029126623 hasRelatedWork W1966219726 @default.
- W2029126623 hasRelatedWork W2070548807 @default.
- W2029126623 hasRelatedWork W2104270787 @default.
- W2029126623 hasRelatedWork W2300006176 @default.
- W2029126623 hasRelatedWork W2564199843 @default.
- W2029126623 hasRelatedWork W2912095776 @default.
- W2029126623 hasRelatedWork W3031492198 @default.
- W2029126623 hasRelatedWork W81344110 @default.
- W2029126623 hasRelatedWork W88626775 @default.
- W2029126623 hasRelatedWork W99701124 @default.
- W2029126623 hasVolume "26" @default.
- W2029126623 isParatext "false" @default.
- W2029126623 isRetracted "false" @default.
- W2029126623 magId "2029126623" @default.
- W2029126623 workType "article" @default.